As of March 2024 Aldeyra Therapeutics has a market cap of $0.19 Billion. This makes Aldeyra Therapeutics the world's 7001th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.19 B | -6.72% |
2023 | $0.20 B | -49.34% |
2022 | $0.40 B | 75.4% |
2021 | $0.23 B | -12.74% |
2020 | $0.26 B | 59.95% |
2019 | $0.16 B | -23.57% |
2018 | $0.21 B | 67.56% |
2017 | $0.13 B | 93.21% |
2016 | $67.28 M | 2.18% |
2015 | $65.85 M | 63.88% |
2014 | $40.18 M |
On Mar 27th, 2024 the market cap of Aldeyra Therapeutics was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Regeneron Pharmaceuticals REGN | $105.64 B | 54,754.99% | ๐บ๐ธ USA |